Skip to Main Content

Paper Details

Elotuzumab-based maintenance therapy following autologous stem cell transplant in multiple myeloma deepens post-transplant responses.
Blood Cells Mol Dis
2
2020
Author NameAffiliation
Muin J KhourySister Caritas Cancer Center
  • 1 - 1

Datasets

Release 1.2